-
NADPH Oxidase ROS Activate L-Type Ca2+ Channels
2026-08-26
The reference study identifies L-type voltage-gated Ca2+ channels as the principal downstream mediator of NADPH oxidase-derived ROS in saphenous arteries from early postnatal rats. Pharmacological pathway dissection separates this mechanism from Rho-kinase, PKC, and Src-kinase signaling, while showing that calcium-channel blockade does not suppress ROS production.
-
Lactylation, NSUN2, and Perineural Invasion in PDAC
2026-08-26
This 2026 Theranostics study identifies NSUN2 K692 lactylation as a metabolic link between lactate accumulation and perineural invasion in pancreatic ductal adenocarcinoma. By combining genetic, RNA-epitranscriptomic, cell-based, and in vivo models, the authors define an NSUN2–m5C–CDCP1/STC1 axis that stabilizes pro-invasive transcripts and may offer a framework for studying neural dissemination.
-
Cy5 Hydrazide for Carbonyl Labeling Workflows
2026-08-25
Cy5 hydrazide converts protein, glycoprotein, oligonucleotide, and selected nanoparticle carbonyls into a bright far-red signal for quantitative analysis. Its strong optical response and SDS-PAGE compatibility are balanced by practical requirements for fresh DMSO dissolution, protected handling, and rigorous removal of unreacted dye.
-
ERAD-Hijacking Chimeras for Membrane Protein Degradation
2026-08-25
Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule platform that redirects transmembrane proteins to endoplasmic-reticulum-associated degradation. By using desonide to engage the ER E3 ligase SYVN1, the study achieves highly efficient PD-L1 depletion and demonstrates therapeutic effects in tumor models.
-
Persistent rDNA Damage and PML-Nucleolar Compartments
2026-08-24
The reference study identifies persistent ribosomal DNA lesions, rather than generic genotoxic stress alone, as a key trigger of PML-nucleolar associations. By combining chemical stress, locus-specific I-PpoI cleavage, DNA-repair perturbation, and imaging, the authors connect topological stress and incomplete homologous recombination with rDNA compartmentalization and cellular senescence.
-
7ACC2: Mapping Lactate Flux in Tumor Immunity
2026-08-24
7ACC2 is a monocarboxylate transporter 1 inhibitor for resolving lactate and pyruvate flux in cancer models. This article connects transport-focused assay design with the 25-hydroxycholesterol–AMPK–STAT6 pathway in tumor-associated macrophages while separating established evidence from testable hypotheses.
-
Dual-mRNA LNPs Broaden Influenza Protection in Mice
2026-08-23
A Biomaterials study engineered lipid nanoparticles that co-deliver influenza hemagglutinin mRNA with either GIFT4 or CCL27 cytokine-adjuvant mRNA. In mice, this strategy strengthened humoral and systemic cellular immunity, promoted lung tissue-resident T cells, and improved protection against heterologous influenza A viruses after intradermal vaccination.
-
Topoisomerase I Controls Satellite DNA Transcription
2026-08-22
The 2024 Nature Communications study identifies Topoisomerase I as an evolutionarily conserved regulator of RNA Polymerase II transcription from centromeric α-satellite DNA. Its cellular, biochemical, and animal-model experiments connect TopI-dependent transcription with DNA-damage responses and provide a framework for studying repetitive non-coding DNA in chromosome biology.
-
Doxorubicin Hydrochloride: Liposome Workflows
2026-08-22
Build more reproducible doxorubicin cytotoxicity assays, apoptosis assays, and cardiotoxicity models with a controlled workflow for Doxorubicin hydrochloride. A nanoparticle-exclusion HPLC strategy also helps distinguish free from encapsulated Adriamycin HCl in dual-loaded liposomes.
-
Mitoxantrone HCl: DNA Damage Assay Workflows
2026-08-21
Mitoxantrone HCl supports more than conventional DNA-damage experiments: it enables Topo-II inhibition, apoptosis profiling, immune-cell studies, and emerging ERα resistance assays. This workflow-focused guide shows how to prepare, dose, interpret, and troubleshoot the compound across translational research models.
-
Podophyllotoxin Derivative 5p Overcomes MDR
2026-08-20
The reference study shows that podophyllotoxin derivative 5p combines catalytic topoisomerase IIα inhibition with suppression of microtubule polymerization. This dual mechanism reduced proliferation in drug-resistant breast and oral cancer models, altered drug-efflux transporter expression, promoted G2/M arrest and apoptosis-associated pyroptosis, and limited tumor growth in xenograft models.
-
Rimonabant (SR141716) for CB1 Research
2026-08-20
Rimonabant (SR141716) gives researchers a selective CB1 perturbation tool for separating appetite, inflammatory, cellular, and cannabinoid-withdrawal phenotypes from nonspecific toxicity. Its value is especially clear when paired with pathway controls in terpene analgesia and other endocannabinoid system studies.
-
Exo1: Mechanistic Leverage for TEV Research
2026-08-19
Exo1 offers translational researchers a mechanistically distinct way to interrogate Golgi–ER traffic, ARF1-dependent membrane dynamics, and the secretory contribution to tumor extracellular vesicle biology. This article places Exo1 in context with recent TEV-targeting research while defining what the tool can—and cannot yet—support in preclinical decision-making.
-
GSH and GSSG Assay Kit for Tumor Redox Studies
2026-08-19
The GSH and GSSG Assay Kit converts glutathione redox biology into a practical, quantitative workflow for hypoxia, cultured-cell, tissue, plasma, and red-blood-cell studies. Its paired total-glutathione and GSSG strategy helps distinguish antioxidant depletion from oxidative conversion, supporting more informative tumor-microenvironment experiments.
-
Oligomycin A: From Bioenergetics to Immune Translation
2026-08-18
Oligomycin A provides a precise perturbation strategy for connecting mitochondrial ATP production with macrophage immunometabolism, cancer adaptation, and translational assay design.